As of this month, about 37 percent of adults 18 and older had received a seasonal flu shot, while 19 percent had received ...

Learn about this vaccine that protects against a common seasonal virus that can sometimes cause severe disease, with info on ...

COVID-19, influenza, and respiratory syncytial virus vaccination coverage is low among adults so far this respiratory virus season (2024 to 2025).

Winter and family holiday gatherings often bring a surge in a wide variety of respiratory issues. Here's what to watch for.

Effectiveness of Maternal Vaccination to Prevent Respiratory Syncytial Virus Illness,” published in the November 2024 issue ...

Respiratory syncytial virus, or RSV, is something many parents know as a cause of bronchiolitis, but others may not have ...

A new Centers for Disease Control and Prevention (CDC) report reveals low uptake of flu, COVID-19 and respiratory syncytial ...

GSK said on Friday that its respiratory syncytial virus (RSV) vaccine has received approval in Japan for expanded use in ...

The goal is to "create a vaccine that prevents the most severe disease manifestations that result in hospitalization or death ...

(HealthDay News) — COVID-19, influenza, and respiratory syncytial virus (RSV) vaccination coverage is low among nursing home residents early in the 2024 to 2025 season, according to research published ...

Some hospitals in the U.S. are seeing an increase in cases of RSV and so-called "walking pneumonia." Here's what you need to ...

FluMist, a self-administered flu vaccine, is approved for ages 2-49, but will be available in the 2025-2026 season. RSV vaccination is vital for older adults, with new guidelines for those aged 60-74, ...